4 unknown, 2 recruiting. 2 Not applicable, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Unknown 2 |
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
Follow Local treatment: new trials by email Literature Review of Local treatment trials Research Report on Local treatment
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploration of Treatment Effect of Novel Hormone Therapy Combined With Local Treatment Based on PSMA PET/CT Evaluation in mHSCP Patients Local treatment, Gonadotropin releasing hormone analog (GnRHa) + Novel hormone therapy (abiraterone, apalutamide or rezvilutamide). - Prostate Cancer Metastatic Disease | Phase 2 | Recruiting | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 192 | 2025-08-01 | 2026-03-25 |
| Observational Clinical Study on Role of MRD in Predicting Local Therapy in Oligometastatic Breast Cancer local treatment - Breast Cancer, MRD | Recruiting | The First Hospital of Jilin University | 40 | 2024-01-01 | 2025-04-09 | |
| Circulating Tumor DNA Guided Therapeutic Strategies for CRC Patients With Small Pulmonary Nodules Local treatment - Advanced Colorectal Cancer, Circulating Tumor DNA | Not applicable | Unknown | Junjie Peng | 100 | 2022-08-01 | 2022-08-10 |
| Real-world Study of Efficacy and Safety of ICIs and TKIs Therapy for HCC Lenvatinib Oral Product, PD-1 inhibitor, Local treatment - Hepatocellular Carcinoma, Programmed Cell Death 1 | Unknown | Tongji Hospital | 2000 | 2021-11-01 | 2022-06-15 | |
| Adjuvant Immunotherapy With Toripalimab Following Curative-intent Ablation for Recurrent Hepatocarcinoma Toripalimab, Thermal ablation - Hepatocellular Carcinoma | Phase 2 | Unknown | Xiangya Hospital of Central South University | 116 | 2020-07-01 | 2022-02-15 |
| Bronchoscopic Microwave Intervention Treatment in Advanced Central NSCLC bronchoscopic microwave intervention, anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy - Effect Increased, Safety Issues | Not applicable | Unknown | Shanghai Pulmonary Hospital, Shanghai, China | 50 | 2020-05-01 | 2020-04-24 |
Carcinoma, Hepatocellular (2) · Breast Neoplasms (1)
Junjie Peng (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1) · Shanghai Pulmonary Hospital, Shanghai, China (1) · The First Hospital of Jilin University (1) · Tongji Hospital (1) · Xiangya Hospital of Central South University (1)
China (5)
Caicun Zhou, MD, PHD (1) · Liangrong Shi, M.D. (1) · Xiaoping Chen, Doctor (1)